Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
3.520
-0.140 (-3.83%)
At close: Dec 20, 2024, 4:00 PM
3.470
-0.050 (-1.42%)
After-hours: Dec 20, 2024, 7:49 PM EST
Sintx Technologies Revenue
Sintx Technologies had revenue of $799.00K in the quarter ending September 30, 2024, with 17.85% growth. This brings the company's revenue in the last twelve months to $3.25M, up 30.40% year-over-year. In the year 2023, Sintx Technologies had annual revenue of $2.63M with 68.29% growth.
Revenue (ttm)
$3.25M
Revenue Growth
+30.40%
P/S Ratio
0.44
Revenue / Employee
$75,512
Employees
43
Market Cap
4.73M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.63M | 1.07M | 68.29% |
Dec 31, 2022 | 1.56M | 955.00K | 157.59% |
Dec 31, 2021 | 606.00K | 12.00K | 2.02% |
Dec 31, 2020 | 594.00K | -95.00K | -13.79% |
Dec 31, 2019 | 689.00K | 594.00K | 625.26% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SunLink Health Systems | 31.81M |
Evaxion Biotech | 3.30M |
Predictive Oncology | 1.48M |
FOXO Technologies | 1.34M |
Syros Pharmaceuticals | 386.00K |
Sonnet BioTherapeutics Holdings | 18.63K |
SINT News
- 4 weeks ago - SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - GlobeNewsWire
- 4 weeks ago - SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer - GlobeNewsWire
- 4 weeks ago - SINTX Technologies Announces Stock Repurchase Program - GlobeNewsWire
- 5 weeks ago - SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 - GlobeNewsWire
- 2 months ago - SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T - GlobeNewsWire
- 3 months ago - Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing” - GlobeNewsWire
- 3 months ago - SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial - GlobeNewsWire
- 6 months ago - SINTX Technologies to Explore Strategic Opportunities - GlobeNewsWire